Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	41	non-cytoplasmic
42	62	transmembrane
63	70	cytoplasmic
71	88	transmembrane
89	93	non-cytoplasmic
94	114	transmembrane
115	132	cytoplasmic
133	150	transmembrane
151	161	non-cytoplasmic
162	182	transmembrane
183	210	cytoplasmic
211	231	transmembrane
232	250	non-cytoplasmic
251	276	transmembrane
277	282	cytoplasmic
283	302	transmembrane
303	307	non-cytoplasmic
308	327	transmembrane
328	347	cytoplasmic
348	369	transmembrane
370	424	non-cytoplasmic
425	444	transmembrane
445	459	cytoplasmic

Input:
>CA265_RS08855
MNVKFRLTIMSFMQFFVWAAWLITIANYWFGTKQWDGADFGIIFSTMGIASLFMPTITGI
LADKWINAERLYAILHILYAATMFYLPQVEDPHTFFWVILVAMCFYMPTIALSNSISYTT
LKNGNFDVVKNFPPIRVWGTVGFIAAMWLTNLTGNKASANQFYIAGVSALMLGLYSFTLP
ACKPLNLISEKKTFAQKLGLESFKLFADYKMALFFIFSMFLGAALQLTNAYGDVFLDEFK
LFPVFAESFVIRYSTIILSISQISETLFILAIPFFLKRFGIKWVIAIAMFAWVLRFGLFA
FGDPSTNLWMIITSCIVYGMAFDFFNISGSLFVETSTTPKTRSSAQGLFMMMTNGFGAVF
GSLVSGWMINKYFTTYYSSIDSLSKYVKSEADNKHLLQFLKNKGISVLENGNLSRALDVK
DWHNIWLSFTIYVLVIAIVFVVIFKHKHTRAEVEAINHL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server